What is apixaban (apixaban)?

Apixaban is a type of medicine known as an anticoagulant – or blood thinner. It makes your blood flow through your veins more easily. This means your blood will be less likely to make a dangerous blood clot. It’s used to treat people who have had a health problem caused by a blood clot such as:

Is apixaban effective in the treatment of stroke?

Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation Apixaban is effective and safe for preventing stroke, and its usage has increased exponentially in recent years.

How long do you have to take apixaban?

If you have had a blood clot (DVT or pulmonary embolism), you’ll normally take apixaban for at least 3 months. Depending on what caused the blood clot, you might need to take it for longer. If you have atrial fibrillation, you might need to take apixaban long term or even for the rest of your life.

What are the side effects of apixaban?

Apixaban prevents blood from clotting normally, so it may take longer than usual for you to stop bleeding if you are cut or injured. This medication may also cause you to bruise or bleed more easily. Call your doctor right away if bleeding or bruising is unusual, severe, or cannot be controlled. Apixaban may cause other side effects.

Can I stop taking apixaban for a short time?

You may need to stop taking apixaban for a short time. Do not stop taking apixaban unless your doctor tells you to. Stopping suddenly can increase your risk of blood clot or stroke. If you stop taking apixaban for any reason, your doctor may prescribe another medication to prevent blood clots until you start taking apixaban again.

Is apixaban safer and more effective than rivaroxaban?

Nonetheless, this analysis supports the findings from prior work in different populations that both apixaban and rivaroxaban have good overall safety and effectiveness profiles, with the possibility that apixaban therapy might be slightly safer and more efficacious.

What are the typical levels of afxaa in patients treated with apixaban?

We also reviewed complications such as major bleeding of patients treated with apixaban. In patients given a 5.0-mg apixaban dose, the median trough and peak levels of AFXaA were 104.5 and 202.0 ng/mL. In patients given a 2.5-mg apixaban dose, the median trough and peak AFXaA levels were 76.0 and 151.0 ng/mL.